Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment
Location: Sweden, Stockholm
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | Flerie Inv... | flerie.com |
Mentions in press and media 2
| Date | Title | Description | Source |
| 31.03.2023 | What M&A slowdown? Buyers circle GreenLight Biosciences,... | While biotech M&A may have cooled down over the past year, no one has told GreenLight Bioscience... | fiercebiot... |
| 04.11.2021 | Interim ReportQ32021 | Interim report January-September 2021 Emcitate® receives FDA Fast Track Designation Financial over... | marketscre... |